Comparison of the efficacy, tolerability, and direct cost of formoterol via the Aerolizer and fenoterol/ipratropium bromide (Berodual) in children with acute asthma.

Trial Profile

Comparison of the efficacy, tolerability, and direct cost of formoterol via the Aerolizer and fenoterol/ipratropium bromide (Berodual) in children with acute asthma.

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Jan 2011

At a glance

  • Drugs Fenoterol/ipratropium bromide (Primary) ; Formoterol (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Jan 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top